Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?
作者信息
Waller D G
机构信息
Clinical Pharmacology Group, Southampton General Hospital.
出版信息
Br J Clin Pharmacol. 1990 Aug;30(2):157-71. doi: 10.1111/j.1365-2125.1990.tb03760.x.
Abstract
摘要
相似文献
1
Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?β-肾上腺素能受体部分激动剂：心血管治疗的复兴？
Br J Clin Pharmacol. 1990 Aug;30(2):157-71. doi: 10.1111/j.1365-2125.1990.tb03760.x.
2
Evaluation of partial beta-adrenoceptor agonist activity.部分β-肾上腺素能受体激动剂活性的评估
Br J Clin Pharmacol. 1997 Jan;43(1):9-14. doi: 10.1111/j.1365-2125.1997.tb00025.x.
3
Are selective beta-adrenoceptor blocking drugs an advantage?选择性β-肾上腺素能受体阻断药有优势吗？
J R Coll Physicians Lond. 1981 Jan;15(1):33-40.
4
Drug bulletin. 1. Beta receptors.
Nurs Mirror. 1982 Sep 1;155(9):59-60.
5
Beta-adrenergic agonists and antagonists.
Contemp Anesth Pract. 1983;7:97-112.
6
COPD and beta-blockers.慢性阻塞性肺疾病与β受体阻滞剂
Compr Ther. 1982 Sep;8(9):3-5.
7
Aspects of the pharmacology of beta-adrenoceptor agonists and antagonists.
Acta Anaesthesiol Scand Suppl. 1982;76:12-9. doi: 10.1111/j.1399-6576.1982.tb01884.x.
8
[Lung function during tocolysis with beta-stimulators and beta-1-blockers].
Z Geburtshilfe Perinatol. 1989 Nov-Dec;193(6):251-5.
9
[Adrenergic beta agonists (adrenaline, dopamine, dobutamine, salbutamol); beta-blockers. Fundamentals and rules of use].
Rev Prat. 1998 May 15;48(10):1115-21.
10
An overview of the pharmacodynamic properties and therapeutic potential of combined alpha- and beta-adrenoceptor antagonists.α-和β-肾上腺素能受体联合拮抗剂的药效学特性及治疗潜力概述
Drugs. 1993 Apr;45(4):509-17. doi: 10.2165/00003495-199345040-00003.
引用本文的文献
1
Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.沙美特罗和福莫特罗预先治疗对气道及全身β2受体对非诺特罗反应的影响。
Thorax. 1996 Jun;51(6):585-9. doi: 10.1136/thx.51.6.585.
2
Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.福莫特罗和沙美特罗的β2肾上腺素能受体激动剂/拮抗剂活性评估。
Thorax. 1996 Jan;51(1):54-8. doi: 10.1136/thx.51.1.54.
3
Effects of dilevalol (R,R-labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients.与硝苯地平相比，双醋洛尔（R,R-拉贝洛尔）对高血压患者静息及运动时心率、血压和肌肉血流的影响。
Br J Clin Pharmacol. 1993 Jun;35(6):623-8. doi: 10.1111/j.1365-2125.1993.tb04192.x.
4
Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.沙丁胺醇的β2肾上腺素能受体部分激动剂/拮抗剂活性在低肾上腺素能张力和高肾上腺素能张力状态下的表现。
Thorax. 1995 Feb;50(2):134-8. doi: 10.1136/thx.50.2.134.
5
Clinical pharmacology through the looking glass: reflections on the racemate vs enantiomer debate.透过镜子看临床药理学：关于外消旋体与对映体争论的思考
Br J Clin Pharmacol. 1991 Jun;31(6):623-5. doi: 10.1111/j.1365-2125.1991.tb05583.x.
6
Cardiac beta 2-adrenoceptors and the inotropic response to exercise in man.心脏β2肾上腺素能受体与人体运动时的变力反应
Clin Auton Res. 1991 Dec;1(4):317-21. doi: 10.1007/BF01819838.
7
The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.选择性β-肾上腺素能受体拮抗剂及部分激动剂活性对正常受试者和中度肾功能损害患者运动期间肾功能的影响。
Br J Clin Pharmacol. 1991 Sep;32(3):387-91. doi: 10.1111/j.1365-2125.1991.tb03917.x.
8
The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.β-肾上腺素能受体拮抗剂（β受体阻滞剂）的应用药理学与临床结局的关系。
Cardiovasc Drugs Ther. 1991 Jun;5(3):561-76. doi: 10.1007/BF03029726.
9
Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography.通过阻抗心动描记法测量普萘洛尔、阿替洛尔和吲哚洛尔的不同心血管效应。
Eur J Clin Pharmacol. 1992;42(1):47-53. doi: 10.1007/BF00314919.
10
Evaluation of in vivo partial beta 1/beta 2-agonist activity: a dose-ranging study with carteolol.体内部分β1/β2激动剂活性的评估：卡替洛尔的剂量范围研究。
Br J Clin Pharmacol. 1992 Apr;33(4):411-6. doi: 10.1111/j.1365-2125.1992.tb04060.x.
本文引用的文献
1
A study of the adrenotropic receptors.促肾上腺受体的研究。
Am J Physiol. 1948 Jun;153(3):586-600. doi: 10.1152/ajplegacy.1948.153.3.586.
2
Selective (beta-1) blockade in congestive cardiomyopathy.充血性心肌病中的选择性（β-1）受体阻滞
Am Heart J. 1983 May;105(5):872-3. doi: 10.1016/0002-8703(83)90261-2.
3
Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris.
Am Heart J. 1982 May;103(5):830-3. doi: 10.1016/0002-8703(82)90395-7.
4
Pindolol in orthostatic hypotension.吲哚洛尔与体位性低血压
Br Med J (Clin Res Ed). 1981 May 23;282(6277):1704. doi: 10.1136/bmj.282.6277.1704-a.
5
Pharmacologic support in cardiogenic shock.心源性休克的药物支持
Adv Shock Res. 1983;10:35-49.
6
Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol.普萘洛尔长期治疗后大鼠淋巴细胞、心脏和肺中β肾上腺素能受体密度的变化。
J Pharmacol Exp Ther. 1982 May;221(2):439-43.
7
The effects of beta 1-adrenoceptor partial agonist ICI 118.587 on left ventricular function in patients with coronary heart disease.
Int J Cardiol. 1984 Mar;5(3):339-49. doi: 10.1016/0167-5273(84)90111-6.
8
The beta-adrenergic blockade withdrawal phenomenon.β-肾上腺素能阻滞剂撤药现象
J Cardiovasc Pharmacol. 1983;5 Suppl 1:S56-62. doi: 10.1097/00005344-198300051-00009.
9
Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.几种β-肾上腺素能受体拮抗剂的急性降压及血管舒张作用机制的研究
J Cardiovasc Pharmacol. 1982 Sep-Oct;4(5):749-58. doi: 10.1097/00005344-198209000-00009.
10
Effect of beta-blocking drugs on peripheral blood flow in intermittent claudication.
J Cardiovasc Pharmacol. 1982 Jan-Feb;4(1):2-4. doi: 10.1097/00005344-198201000-00002.
Zotero 插件